Is ADH1B destiny or just a small risk factor?

Is ADH1B destiny or just a small risk factor? The answer is clear: it is a moderate risk factor, not destiny. ADH1B encodes alcohol dehydrogenase, which metabolizes ethanol to acetaldehyde. Certain variants (e.g., ADH1B*2) cause faster metabolism and higher acetaldehyde levels, leading to unpleasant effects like flushing and nausea. This reduces the risk of alcohol dependence and alcohol-related cancers (e.g., esophageal cancer). The effect size is moderate: carriers of the *2 allele have about a 2- to 4-fold lower risk of alcohol dependence. However, the effect is modulated by environmental factors, social norms, and other genes (e.g., ALDH2). The variant is common in East Asian populations but rare in Europeans. A single gene test cannot predict actual alcohol consumption or health outcomes. Evidence comes from robust GWAS and meta-analyses, but clinical predictive power is limited. In summary, ADH1B is a meaningful but non-deterministic factor; lifestyle and environment play a larger role.